Google+ Badge

Friday, November 20, 2015

Fit Firm and Fabulous is recalling Ultimate Herbal Slimcap capsules

Fit Firm and Fabulous is voluntarily recalling lots 05/02/2015 to 05/01/2017 of Ultimate Herbal Slimcap capsules, to the consumer level. FDA analysis has found the product to contain undeclared sibutramine. Sibutramine was a previously approved controlled substance that was removed from the U.S. market in October 2010 for safety reasons. This ingredient makes Ultimate Herbal Slimcap an unapproved drug for which safety and efficacy have not been established and, therefore, subject to recall.
Products containing sibutramine pose a threat to consumers because sibutramine is known to substantially increase blood pressure and/or pulse rate in some patients and may present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias or stroke. These products may also interact in life threatening ways with other medications a consumer may be taking. To date, Fit Firm and Fabulous has not received any reports of adverse events related to this recall.
The product is a dietary supplement marketed for weight loss and is packaged in 30-count bottles, labeled Part 1 of 3, UPC 5 42423 25422 1. The affected Ultimate Herbal Slimcap lots include the following lots 05/02/2015 to 05/01/2017. The product can be identified by. Ultimate Herbal Slimcaps was distributed Nationwide via the website.
Fit Firm and Fabulous has notified its distributors and customers by telephone and has arranged for return or destroy of all recalled products. Consumers/distributors/retailers that have product which is being recalled should stop using and discard.
Consumers with questions regarding this recall can contact Fit Firm and Fabulous by e-mail at customerservice@fitfirmandfabulous.com on Monday through Friday from 9 am EST and 5 pm EST Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product.
Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax.

No comments:

Post a Comment